The Department of Science and Technology (DOST) Secretary Fortunato de la Peña stated that Pfizer's claim of 90 percent vaccine effectiveness can only be verified if clinical trials are conducted in the Philippines.
He mentioned that if Pfizer applies for a clinical trial in the Philippines, the data gathered will be reviewed by the Vaccine Expert Panel (VEP).
Dela Peña emphasized that the details and supporting data for the 90 percent effectiveness claim are currently unknown to the local authorities.
Even if Pfizer does not conduct trials and instead applies for supply purposes, the submitted data will still be referred to the VEP for analysis.
Philippine regulations require data from Phase 3 clinical trials to be included in such applications.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.



